Kristy Brady

    • Vir Biotechnology - $143 Million IPO 

    • Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million 

    • Silence Therapeutics Enters Collaboration With Mallinckrodt Worth up to $2 Billion 

    • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 

    • Rigel Pharmaceuticals License and Supply Agreement with Kissei Pharmaceutical Valued up to $180 Million 

    • Lodo Therapeutics Enters $970 Million Multi-Target Collaboration With Genentech 

    • Turnstone Biologics License Agreement with AbbVie 

    • Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan